These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38629583)

  • 1. Indicators of cure for women living after uterine and ovarian cancers: a population-based study.
    Giudici F; De Paoli A; Toffolutti F; Guzzinati S; Francisci S; Bucchi L; Gatta G; Demuru E; Mallone S; Cin AD; Caldarella A; Cuccaro F; Migliore E; Gambino ML; Ravaioli A; Puppo A; Ferrante M; Carrozzi G; Stracci F; Musolino A; Gasparotti C; Cavallo R; Mazzucco W; Vitale MF; Cascone G; Ballotari P; Ferretti S; Mangone L; Rizzello RV; Sampietro G; Mian M; Boschetti L; Galasso R; Bella F; Piras D; Sessa A; Seghini P; Fanetti AC; Pinna P; De Angelis R; Serraino D; Maso LD; Working Group A
    Am J Epidemiol; 2024 Apr; ():. PubMed ID: 38629583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Italian cancer figures, report 2014: Prevalence and cure of cancer in Italy.
    AIRTUM Working Group
    Epidemiol Prev; 2014; 38(6 Suppl 1):1-122. PubMed ID: 25759295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cure indicators and prevalence by stage at diagnosis for breast and colorectal cancer patients: A population-based study in Italy.
    Dal Maso L; Toffolutti F; De Paoli A; Giudici F; Francisci S; Bucchi L; Zorzi M; Fusco M; Caldarella A; Rossi S; De Angelis R; Botta L; Ravaioli A; Casella C; Musolino A; Vitale MF; Mangone L; Fanetti AC; Carpin E; Burgio Lo Monaco MG; Migliore E; Gambino ML; Ferrante M; Stracci F; Gasparotti C; Carrozzi G; Cavallo R; Mazzucco W; Ballotari P; Ferretti S; Sampietro G; Rizzello RV; Boschetti L; Cascone G; Mian M; Pesce MT; Piras D; Galasso R; Bella F; Seghini P; Pinna P; Crocetti E; Serraino D; Guzzinati S;
    Int J Cancer; 2024 Jul; 155(2):270-281. PubMed ID: 38520231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complete prevalence and indicators of cancer cure: enhanced methods and validation in Italian population-based cancer registries.
    Toffolutti F; Guzzinati S; De Paoli A; Francisci S; De Angelis R; Crocetti E; Botta L; Rossi S; Mallone S; Zorzi M; Manneschi G; Bidoli E; Ravaioli A; Cuccaro F; Migliore E; Puppo A; Ferrante M; Gasparotti C; Gambino M; Carrozzi G; Stracci F; Michiara M; Cavallo R; Mazzucco W; Fusco M; Ballotari P; Sampietro G; Ferretti S; Mangone L; Rizzello RV; Mian M; Cascone G; Boschetti L; Galasso R; Piras D; Pesce MT; Bella F; Seghini P; Fanetti AC; Pinna P; Serraino D; Dal Maso L;
    Front Oncol; 2023; 13():1168325. PubMed ID: 37346072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term survival, prevalence, and cure of cancer: a population-based estimation for 818 902 Italian patients and 26 cancer types.
    Dal Maso L; Guzzinati S; Buzzoni C; Capocaccia R; Serraino D; Caldarella A; Dei Tos AP; Falcini F; Autelitano M; Masanotti G; Ferretti S; Tisano F; Tirelli U; Crocetti E; De Angelis R; ; Virdone S; Zucchetto A; Gigli A; Francisci S; Baili P; Gatta G; Castaing M; Zanetti R; Contiero P; Bidoli E; Vercelli M; Michiara M; Federico M; Senatore G; Pannozzo F; Vicentini M; Bulatko A; Pirino DR; Gentilini M; Fusco M; Giacomin A; Fanetti AC; Cusimano R
    Ann Oncol; 2014 Nov; 25(11):2251-2260. PubMed ID: 25149707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of Malignant Cervical, Corpus Uteri and Ovarian Tumours - Current Data and Epidemiological Trends.
    Waldmann A; Eisemann N; Katalinic A
    Geburtshilfe Frauenheilkd; 2013 Feb; 73(2):123-129. PubMed ID: 24771908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Italian cancer figures, report 2010: Cancer prevalence in Italy. Patients living with cancer, long-term survivors and cured patients.
    AIRTUM Working Group
    Epidemiol Prev; 2010; 34(5-6 Suppl 2):1-188. PubMed ID: 21220827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and prevalence of drugs used for chronic diseases in survivors of adult-onset gynaecological cancer - A nationwide cohort study.
    Bjørge T; Hjellvik V; Bjørge L; Dos-Santos-Silva I; Furu K; Kvåle R; Engeland A
    BJOG; 2023 Jun; 130(7):770-778. PubMed ID: 36700296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer cure for 32 cancer types: results from the EUROCARE-5 study.
    Dal Maso L; Panato C; Tavilla A; Guzzinati S; Serraino D; Mallone S; Botta L; Boussari O; Capocaccia R; Colonna M; Crocetti E; Dumas A; Dyba T; Franceschi S; Gatta G; Gigli A; Giusti F; Jooste V; Minicozzi P; Neamtiu L; Romain G; Zorzi M; De Angelis R; Francisci S;
    Int J Epidemiol; 2020 Oct; 49(5):1517-1525. PubMed ID: 32984907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Italian cancer figures, report 2013: Multiple tumours.
    AIRTUM Working Group
    Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reliability of recording uterine cancer in death certification in France and age-specific proportions of deaths from cervix and corpus uteri.
    Rogel A; Belot A; Suzan F; Bossard N; Boussac M; Arveux P; Buémi A; Colonna M; Danzon A; Ganry O; Guizard AV; Grosclaude P; Velten M; Jougla E; Iwaz J; Estève J; Chérié-Challine L; Remontet L
    Cancer Epidemiol; 2011 Jun; 35(3):243-9. PubMed ID: 21106450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival of gynecological cancers in Turkey: where are we at?
    Gultekin M; Dundar S; Kucukyildiz I; Karaca MZ; Boztas G; Turan SH; Hacikamiloglu E; Keskinkilic B
    J Gynecol Oncol; 2017 Nov; 28(6):e85. PubMed ID: 29027403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognosis and cure of long-term cancer survivors: A population-based estimation.
    Dal Maso L; Panato C; Guzzinati S; Serraino D; Francisci S; Botta L; Capocaccia R; Tavilla A; Gigli A; Crocetti E; Rugge M; Tagliabue G; Filiberti RA; Carrozzi G; Michiara M; Ferretti S; Cesaraccio R; Tumino R; Falcini F; Stracci F; Torrisi A; Mazzoleni G; Fusco M; Rosso S; Tisano F; Fanetti AC; Sini GM; Buzzoni C; De Angelis R;
    Cancer Med; 2019 Aug; 8(9):4497-4507. PubMed ID: 31207165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology of gynecological cancers in Kamrup Urban District cancer registry.
    Barman D; Sharma JD; Barmon D; Kataki AC; Sharma A; Kalita M
    Indian J Cancer; 2017; 54(1):388-391. PubMed ID: 29199729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Second cancer following cancer of the female genital system in Connecticut, 1935-82.
    Curtis RE; Hoover RN; Kleinerman RA; Harvey EB
    Natl Cancer Inst Monogr; 1985 Dec; 68():113-37. PubMed ID: 4088293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in the survival of patients diagnosed with cancer in female genital organs in the Nordic countries 1964-2003 followed up to the end of 2006.
    Klint A; Tryggvadóttir L; Bray F; Gislum M; Hakulinen T; Storm HH; Engholm G
    Acta Oncol; 2010 Jun; 49(5):632-43. PubMed ID: 20307243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer Cure and Consequences on Survivorship Care: Position Paper from the Italian Alliance Against Cancer (ACC) Survivorship Care Working Group.
    Dal Maso L; Santoro A; Iannelli E; De Paoli P; Minoia C; Pinto M; Bertuzzi AF; Serraino D; De Angelis R; Trama A; Haupt R; Pravettoni G; Perrone M; De Lorenzo F; Tralongo P;
    Cancer Manag Res; 2022; 14():3105-3118. PubMed ID: 36340999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mortality impact, risks, and benefits of general population screening for ovarian cancer: the UKCTOCS randomised controlled trial.
    Menon U; Gentry-Maharaj A; Burnell M; Ryan A; Kalsi JK; Singh N; Dawnay A; Fallowfield L; McGuire AJ; Campbell S; Skates SJ; Parmar M; Jacobs IJ
    Health Technol Assess; 2023 May; ():1-81. PubMed ID: 37183782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.